Early Access — free while we kick the tires
EdgarHawk

ESLA Estrella Immunopharma, Inc. Insider Trading

Latest: CFO Bought $2,594 of Shares · Oct 2025
1 filing analyzed · Latest 2026-04-29
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
April 2026
2026-04-29
medium
Xu Jiandong Buy
Chief Financial Officer
2,100 shares
$2,594
@ $1.24
Significance 4/10

CFO Xu Jiandong bought 2,100 shares (3 purchases, $1.04–$1.33 range) amid -$4.8M net loss; stock up 42.7% in 30 days from $1.04 base.

Xu Jiandong, Chief Financial Officer, executed three separate purchases totaling 2,100 shares for $2,594.00 across September and October 2025, at prices ranging from $1.04 to $1.33 with a blended average of $1.24. The timing of these purchases coincides with significant upward price momentum: the stock has climbed 42.7% over the prior 30 days and 36.1% over 90 days, suggesting the purchases began near recent lows relative to recent trading. However, context is material: the company reported a full-year net loss of $-4,801,149.00 and remains unprofitable. The CFO's modest accumulation—a 0.8% increase in his 265.5K-share post-transaction holdings—occurs against a stock now trading at $1.47, down 51.8% from its 52-week high of $3.05. This filing documents insider buying activity during a recovery phase in an unprofitable company.

Get alerts for ESLA

Add ESLA to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access